News Image

Delving into NASDAQ:MEDP's Growth Prospects.

By Mill Chart

Last update: Sep 27, 2023

In this article we will dive into MEDPACE HOLDINGS INC (NASDAQ:MEDP) as a possible candidate for growth investing. Investors should always do their own research, but we noticed MEDPACE HOLDINGS INC showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.

What matters for canslim investors.

  • In the most recent financial report, MEDPACE HOLDINGS INC reported a 32.19% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
  • MEDPACE HOLDINGS INC has achieved significant quarter-to-quarter (Q2Q) revenue growth of 31.22%, signaling its ability to capture market opportunities and drive top-line expansion. This growth underscores the company's effective execution and its potential for continued success.
  • The EPS of MEDPACE HOLDINGS INC has shown consistent growth over a 3-year period, indicating the company's ability to generate increasing earnings over time.
  • MEDPACE HOLDINGS INC showcases a robust Return on Equity (ROE) of 68.65%, indicating its ability to generate favorable returns for shareholders. This metric underscores the company's efficiency in utilizing its equity capital to generate profits.
  • MEDPACE HOLDINGS INC has exhibited strong Relative Strength(RS) in recent periods, with a current 92.43 rating. This indicates the stock's ability to outperform the broader market and reflects its competitive position. MEDPACE HOLDINGS INC shows promising potential for continued price momentum.
  • MEDPACE HOLDINGS INC exhibits a favorable Debt-to-Equity ratio at 0.14. This highlights the company's ability to limit excessive debt levels and maintain a strong equity base, demonstrating its financial stability and risk management practices.
  • MEDPACE HOLDINGS INC demonstrates a balanced ownership structure, with institutional shareholders at 77.02%. This indicates a diverse investor base, which can contribute to price stability and potential future growth.

Technical analysis of NASDAQ:MEDP

ChartMill assigns a proprietary Technical Rating to each stock. The score is computed daily by evaluating various technical indicators and properties. The score ranges from 0 to 10.

Taking everything into account, MEDP scores 5 out of 10 in our technical rating. This is due to a consistent overall performance, although we see some doubts in the very recent evolution. In the medium time frame things are still looking good.

  • Looking at the yearly performance, MEDP did better than 92% of all other stocks. We also observe that the gains produced by MEDP over the past year are nicely spread over this period.
  • MEDP is one of the better performing stocks in the Life Sciences Tools & Services industry, it outperforms 93% of 64 stocks in the same industry.
  • MEDP is currently trading in the upper part of its 52 week range. The S&P500 Index is also trading in the upper part of its 52 week range, so MEDP is performing more or less in line with the market.
  • The long term trend is positive and the short term trend is negative. It is probably better to wait until this picture becomes clearer.

Check the latest full technical report of MEDP for a complete technical analysis.

What else is there to say on the fundamentals of NASDAQ:MEDP?

At ChartMill, a crucial aspect of their analysis is the assignment of a Fundamental Rating to each stock. This rating, ranging from 0 to 10, is calculated daily by considering numerous fundamental indicators and properties.

Taking everything into account, MEDP scores 7 out of 10 in our fundamental rating. MEDP was compared to 64 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making MEDP a very profitable company, without any liquidiy or solvency issues. MEDP is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make MEDP suitable for growth and quality investing!

Our latest full fundamental report of MEDP contains the most current fundamental analsysis.

Our CANSLIM screen will find you more ideas suited for growth investing.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

MEDPACE HOLDINGS INC

NASDAQ:MEDP (4/26/2024, 7:03:06 PM)

After market: 395.93 0 (0%)

395.93

+6.16 (+1.58%)

MEDP News

News Imagea day ago - Investor's Business DailyStock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review

Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.

News Image5 days ago - InvestorPlaceMEDP Stock Earnings: Medpace Hldgs Beats EPS, Misses Revenue for Q1 2024

MEDP stock results show that Medpace Hldgs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

News Image5 days ago - BusinessInsiderMEDP Stock Earnings: Medpace Hldgs Beats EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Medpace Hldgs (NASDAQ:MEDP) just reported results for the first quarter of 2024...

News Image5 days ago - Medpace Holdings, Inc.Medpace Holdings, Inc. Reports First Quarter 2024 Results
News Image5 days ago - Market News VideoNoteworthy Monday Option Activity: MEDP, DUK, FUBO
News Imagea month ago - Investor's Business DailyUber Leads Five Stocks Near Buy Points

Five resilient stocks are setting up or flirting with entries.

News Imagea month ago - Medpace Holdings, Inc.Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
News Image2 months ago - Investor's Business DailyThermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months

Thermo Fisher stock has risen more than 40% since October. Additionally, it's closed higher nine of the past 11 trading sessions.

News Image2 months ago - Investor's Business DailyAgilent Technologies Stock Getting Closer To Key Technical Benchmark

Agilent Technologies stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 65 to 71.

MEDP Links
Follow us for more